Clinical Trial Update: Study of DS-7080a for the Treatment of Macular Degeneration [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating DS-7080a for neovascular age-related macular degeneration and diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• DS-7080a

Snippet

Sponsor: Daiichi Sankyo | Conditions: Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema | Phase 1 | Status: COMPLETED